By: Gregory Laub From: medpagetoday.com After the results of CLEOPATRA, taxane chemotherapy with dual anti-HER2-blocker therapy Herceptin [trastuzumab]/Perjeta [pertuzumab] became the standard of care for HER2-positive metastatic breast cancer. With this study, we were looking to see how many patients in the real world received that regimen as a first-line standard-of-care therapy, which we defined as “1LSOC” compared to an …
Be an inspiration today. You don’t need …
“Be an inspiration today. You don’t need to be a success story to inspire someone. A small push towards their dream can make a big difference. – Siam Mehraf” Siam Mehraf Barbara JacobyBarbara Jacoby is an award winning blogger that has contributed her writings to multiple online publications that have touched readers worldwide. LetLifeHappen.com
DETECT V: HER2+, HR+ Metastatic Breast Cancer can be Safely Treated Without Chemotherapy
By: Vicki Moore, PhD From: cancertherapyadvisor.com It may be possible to safely omit chemotherapy for patients with HER2-positive, hormone receptor (HR)-positive metastatic breast cancer, according to an updated analysis of the DETECT V study. Wolfgang Janni, MD, PhD, of the University Hospital Ulm in Ulm, Germany presented the findings at the San Antonio Breast Cancer Symposium 2025. The randomized, multicenter, …
If anyone acknowledges that …
If anyone acknowledges that Jesus is the Son of God, God lives in them and they in God. 1 John 4:15 Barbara JacobyBarbara Jacoby is an award winning blogger that has contributed her writings to multiple online publications that have touched readers worldwide. LetLifeHappen.com
Don’t be afraid to lose yourself in fantasy, when …
“Don’t be afraid to lose yourself in fantasy, when you find your way back to reality, it’s easier to deal with.” – D.M. Williams, Barlow Definition of Flawless Barbara JacobyBarbara Jacoby is an award winning blogger that has contributed her writings to multiple online publications that have touched readers worldwide. LetLifeHappen.com
What to Know About Metastatic Breast Cancer in Your 50s
From: healthline.com Although the average age of diagnosis for breast cancer in the United States is 62 yearsTrusted Source, the condition can also affect people in their 50s or at a younger age. Metastatic breast cancer (MBC) occurs when breast cancer spreads from your breast to other parts of your body. There’s currently no cure for MBC, but treatment may …
“Mind is not an entity inside the brain with …
“Mind is not an entity inside the brain with the power to go against Life, Truth, and Love, now or anytime.” – Cheryl Petersen, 21st Century Science and Health with Key to the Scriptures: A revision of Mary Baker Eddy’s Science and Health Barbara JacobyBarbara Jacoby is an award winning blogger that has contributed her writings to multiple online publications …
Novel endocrine therapy reduces the risk of breast cancer recurrence
By Denise Heady, MA From: uclahealth.org In an international study led by UCLA, researchers have shown that giredestrant, a next-generation oral selective estrogen receptor antagonist and degrader (SERD), when given as an adjuvant therapy for early-stage (1-3) hormone receptor (HR)-positive, HER2-negative breast cancer, significantly lowered the risk of the disease returning when compared with standard hormone therapies long considered the …
If you want to achieve excellence ..
“If you want to achieve excellence you can’t do what the average person does you either have to do things differently or better.” – Kerlan London Barbara JacobyBarbara Jacoby is an award winning blogger that has contributed her writings to multiple online publications that have touched readers worldwide. LetLifeHappen.com
How Pharmacists Help Drive Precision Oncology in Metastatic Breast Cancer
By: Danielle Valletti, Assistant Editor, Siddhartha Yadav, M.B.B.S., M.D. From: .pharmacytimes.com Pharmacists play a vital role in precision oncology, enhancing treatment decisions for metastatic breast cancer through genetic testing and targeted therapies. At the 2025 San Antonio Breast Cancer Symposium (SABCS), Siddhartha Yadav, MBBS, MD, discussed the critical and expanding role of pharmacists in precision oncology and biomarker-driven treatment decision-making …